Lev Dykman

Lev Dykman

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 November 2016 in Chemical Science
Verified
Journal Article
Open access
PDF file
LDLev Dykman
Lev Dykman
BKBoris Khlebtsov
Boris Khlebtsov
In the past decade, gold nanoparticles have attracted strong interest from the nanobiotechnological community owing to the significant progress made in robust and easy-to-make synthesis technologies, in surface functionalization, and in promising biomedical applications. These include bioimaging, gene diagnostics, analytical sensing, photothermal treatment of tumors, and targeted delivery of various biomolecular and chemical cargos. For the last-named application, gold nanoparticles should be properly fabricated to deliver the cargo into the targeted cells through effective endocytosis. In this review, we discuss recent progress in understanding the selective penetration of gold nanoparticles into immune cells. The interaction of gold nanoparticles with immune cell receptors is discussed. As distinct from other published reviews, we present a summary of the immunological properties of gold nanoparticles. This review also summarizes what is known about the application of gold nanoparticles as an antigen carrier and adjuvant in immunization for the preparation of antibodies in vivo. For each of the above topics, the basic principles, recent advances, and current challenges are discussed. Thus, this review presents a detailed analysis of data on interaction of gold nanoparticles with immune cells. Emphasis is placed on the systematization of data over production of antibodies by using gold nanoparticles and adjuvant properties of gold nanoparticles. Specifically, we start our discussion with current data on interaction of various gold nanoparticles with immune cells. The next section describes existing technologies to improve production of antibodies in vivo by using gold nanoparticles conjugated with specific ligands. Finally, we describe what is known about adjuvant properties of bare gold or functionalized nanoparticles. In the Conclusion section, we present a short summary of reported data and some challenges and perspectives.

28 April 2020 in Expert Review of Vaccines
Verified
Journal Article
Closed access
LDLev Dykman
Lev Dykman
Vaccination remains very effective in stimulating protective immune responses against infections. An important task in antibody and vaccine preparation is to choose an optimal carrier that will ens...

1 November 2016 in Biomaterials
Verified
Journal Article
Closed access
LDLev Dykman
Lev Dykman
NKNikolai G. Khlebtsov
Nikolai G. Khlebtsov

1 January 2018 in International Immunopharmacology
Verified
Journal Article
Closed access
LDLev Dykman
Lev Dykman
SSSergey Staroverov
Sergey Staroverov
AFAlexander S. Fomin
Alexander S. Fomin
VKVitaly A. Khanadeev
Vitaly A. Khanadeev
BKBoris Khlebtsov
Boris Khlebtsov
VBVladimir A. Bogatyrev
Vladimir A. Bogatyrev

7 June 2019 in Biomedical Optics Express
Verified
Journal Article
Closed access
PDF file
LDLev Dykman
Lev Dykman
BKBoris Khlebtsov
Boris Khlebtsov
Functionalized gold nanoparticles (GNPs) with controlled geometrical and optical properties have been the subject of intense research and biomedical applications. This review summarizes recent data and topical problems in nanomedicine that are related to the use of variously sized, shaped, and structured GNPs. We focus on three topical fields in current nanomedicine: (1) use of GNP-based nanoplatforms for the targeted delivery of anticancer and antimicrobial drugs and of genes; (2) GNP-based cancer immunotherapy; and (3) combined chemo-, immuno-, and phototherapy. We present a summary of the available literature data and a short discussion of future work.

23 August 2011 in Bulletin of Experimental Biology and Medicine
Verified
Journal Article
Closed access
PDF file
SSSergey Staroverov
Sergey Staroverov
IVI. V. Vidyasheva
I. V. Vidyasheva
KGK. P. Gabalov
K. P. Gabalov
OVO. A. Vasilenko
O. A. Vasilenko
VLV. N. Laskavyi
V. N. Laskavyi
LDLev Dykman
Lev Dykman